Senator Elizabeth Warren, D-Mass., Right, and Tina Smith, D-Minn., Speak to attendees at a Senate Health, Education, Labor, and Pensions Committee hearing on September 25, 2018.
Tom Williams | CQ Roll Call, Inc. | Getty Images
Sens Elizabeth Warren, Tina Smith and Marco Rubio on Thursday reintroduced two laws to secure the U.S. drug supply chain by reducing reliance on China and other nations for the supply of life-saving drugs and vaccines.
The Food and Drug Administration estimates that 80% of manufacturers who make drug ingredients are based outside of the United States, many of them in China and India. Although the agency has closely monitored the supply chain, it does not have a clear understanding of where drug components are made.
The US experienced a shortage of drugs to treat Covid-19 patients during the pandemic as demand increased but supply was disrupted due to factory closures and delays in shipping.
“In order to overcome the current COVID-19 crisis and better equip the USA against future pandemics, we must increase our country’s production capacity.” Warren, D-Mass., Said. “Our bill will end our over-reliance on foreign countries and give us the tools we need to create the critical medicines that millions of Americans depend on here at home.”
Warren and Smith, D-Minn., First introduced the Pharmaceutical Supply Chain Defense and Improvement Act in June 2020.
The bill requires the Food and Drug Administration Commissioner and Secretary of Defense to establish a confidential list of “critical drugs”, allocate $ 5 billion to invest in domestic manufacturing, and require drug manufacturers to report the source of their materials to the FDA.
Senators Warren and Rubio, R-Fla., Are also improving legislation first introduced last year to order the Federal Trade Commission and the Treasury Department to conduct a study of the US Foreign Investment Committee.
“COVID-19 has made it painfully clear that we must pass meaningful laws to help rebuild our country’s medical manufacturing and pharmaceuticals sectors,” said Rubio.
The bill is designed to understand how foreign direct investment will affect the country’s ability to manufacture drugs, as well as US genome sequencing and DNA storage.
President Joe Biden’s American Jobs Act calls for $ 30 billion in investment to protect Americans from future pandemics. This includes efforts to bring pharmaceutical ingredient manufacturing back to the United States
The legislator fears that foreign manufacturers could restrict the supply of critical pharmaceutical components or even stop them altogether if geopolitical tensions increase. Bad actors could manipulate drugs to render them ineffective or arm them.